Rare Disease Report: Is Eteplirsen Effective in Non-ambulatory Duchenne Patients?

Christine McSherry, founder of the Jett Foundation talks about her son’s experience as a non-ambulatory Duchenne muscular dystrophy patient taking Sarepta’s eteplirsen.

SOURCE | RARE DISEASE REPORT